Jun-kyu Hwang | Neurosurgery | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof. Jun-kyu Hwang | Neurosurgery | Best Researcher Award

Dr. Jun Kyu Hwang is a Clinical Assistant Professor in the Department of Neurosurgery at Yongin Severance Hospital, affiliated with Yonsei University College of Medicine in Korea. He earned his M.D. from Yonsei University in 2010 and later pursued a Master’s and currently a Ph.D. in Neurosurgery at the same institution. With extensive clinical training and fellowships in pediatric and general neurosurgery at prestigious institutions including Severance Hospital and Asan Medical Center, Dr. Hwang has built a robust academic and clinical foundation. Since 2021, he has been serving in his current role, contributing to surgical education, clinical practice, and neurosurgical research. His work spans advanced neurosurgical procedures, clinical innovation, and academic mentorship. He is known for his dedication to patient care, surgical precision, and academic rigor. Dr. Hwang’s career reflects his commitment to advancing neurosurgical practice through a combination of hands-on experience and continued academic pursuit.

Profile

🎓 Education

Dr. Hwang completed his M.D. degree at Yonsei University College of Medicine in 2010, laying the groundwork for a career dedicated to neuroscience and clinical surgery. Driven by academic excellence and a passion for neurosurgery, he further obtained a Master’s degree in Neurosurgery from the Graduate School of Yonsei University between 2016 and 2019. His postgraduate educational journey reflects a focus on deepening his expertise in surgical techniques, neurological pathology, and clinical outcomes. Continuing this academic momentum, he is currently pursuing a Ph.D. in Neurosurgery at Yonsei University. This doctoral work demonstrates his strong interest in neurosurgical innovation and research, with a commitment to integrating scientific advancement into clinical practice. His education spans both rigorous academic study and immersive clinical training, forming a comprehensive foundation for excellence in neurosurgical care and research. Dr. Hwang’s ongoing academic endeavors ensure that he remains at the forefront of modern neurosurgical developments.

🧪 Experience

Dr. Hwang began his clinical journey with a neurosurgical residency at Severance Hospital, Yonsei University from 2014 to 2017, where he gained comprehensive surgical and clinical experience. He continued his training as a Clinical Fellow in Pediatric Neurosurgery at Severance Hospital in 2018, focusing on the surgical treatment of neurological conditions in children. From 2019 to 2020, he expanded his expertise through a fellowship at Asan Medical Center under the University of Ulsan, specializing further in complex neurosurgical procedures. In 2021, he assumed the role of Clinical Assistant Professor in the Department of Neurosurgery at Yongin Severance Hospital, Yonsei University. His professional roles have encompassed patient care, surgical instruction, and clinical mentorship. Dr. Hwang’s experience reflects a trajectory of increasing responsibility, technical refinement, and dedication to both adult and pediatric neurosurgical practice. He continues to contribute significantly to clinical excellence, resident education, and research development in neurosurgery.

🏅 Awards and Honors

While specific awards and honors are not listed in the provided CV, Dr. Jun Kyu Hwang’s prestigious appointments and continuous academic advancement signify professional recognition and trust by leading medical institutions. His acceptance into competitive fellowships at Severance Hospital and Asan Medical Center—two of Korea’s top medical centers—reflect his exceptional competence and commitment to excellence. His transition from residency to fellowship and then to Clinical Assistant Professor at Yongin Severance Hospital is itself a mark of distinction. Typically, such roles are conferred upon individuals who demonstrate not only strong clinical capabilities but also promise in academic and research contributions. His ongoing Ph.D. candidacy at Yonsei University also indicates academic recognition and support for his scholarly potential. These milestones together point to a career distinguished by merit-based progression, institutional confidence, and high standards of patient care and medical professionalism.

🔬 Research Focus

Dr. Hwang’s research focuses on the clinical and surgical aspects of neurosurgery, with a particular interest in pediatric neurosurgery, advanced surgical techniques, and neuro-oncology. His academic pathway, including a Master’s and ongoing Ph.D. in Neurosurgery, is aligned with investigating surgical outcomes, improving procedural methodologies, and exploring innovative approaches to treating neurological disorders. His clinical fellowships and continued academic pursuits suggest involvement in translational research—bridging laboratory findings with clinical applications. As a Clinical Assistant Professor, he likely collaborates in institutional research initiatives, contributes to clinical trials, and mentors junior researchers. His research aims to enhance precision in neurosurgical interventions, reduce complications, and improve recovery outcomes, particularly in pediatric populations. With experience in high-volume tertiary hospitals, Dr. Hwang integrates his research with real-world patient care, contributing data-driven insights to the academic community. His long-term vision likely involves developing safer, more effective neurosurgical strategies through evidence-based practice.

✅ Conclusion

Dr. Jun Kyu Hwang exemplifies a dedicated neurosurgeon committed to academic excellence, clinical expertise, and research innovation, making impactful contributions to both patient care and the neurosurgical field in Korea.

Faheem Arshad | Cognitive Neurosciences | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Faheem Arshad | Cognitive Neurosciences | Best Researcher Award

Dr. Faheem Arshad is an Assistant Professor of Neurology at the National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru. A leading cognitive neurologist in India, he specializes in dementia and neurodegenerative disorders. He played a pivotal role in establishing India’s first cognitive disorders registry at NIMHANS, integrating clinical and research excellence. Dr. Arshad is a Senior Atlantic Fellow for Equity in Brain Health at the University of California, San Francisco (UCSF), and the first fellow from South Asia. His research integrates neurogenetics, biomarkers, imaging, and clinical trials, with a focus on inclusivity and low-literacy populations. He actively contributes to national and international collaborations and holds leadership roles within Indian and global neurology communities. Committed to early diagnosis, caregiver support, and prevention strategies, his work aims to improve brain health equity in diverse settings. His ongoing studies explore social interaction, bilingualism, and digital tools in dementia management.

Profile

Education 🎓

Dr. Arshad received his foundational training in Internal Medicine (MD, 2014) at Sher-i-Kashmir Institute of Medical Sciences (SKIMS), Kashmir. He served as Registrar in Internal Medicine at AIIMS, New Delhi until 2016. He pursued advanced neurological training at the National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, earning a DM in Neurology (2019) and completing a Post-Doctoral Fellowship in Cognitive Neurosciences (2020). He furthered his expertise with a prestigious international fellowship in Global Brain Health Equity at the Global Brain Health Institute (GBHI), University of California, San Francisco (UCSF), USA in 2021. Dr. Arshad also holds the MRCP(UK) Neurology credential (2020), reflecting global competence. His multidisciplinary training spans cognitive neurology, imaging, biomarkers, and dementia prevention, equipping him with a holistic approach to brain health research and patient care.

Experience 👨‍🏫

Dr. Faheem Arshad’s professional journey spans over a decade of clinical, academic, and research excellence. He is currently Assistant Professor of Neurology at NIMHANS, Bengaluru, where he has led initiatives in cognitive neurology since 2021. His early training included roles as Junior and Senior Resident in Internal Medicine at SKIMS and AIIMS, followed by Neurology Residency and Postdoctoral Fellowship at NIMHANS. He became a faculty leader and Convener of the Cognitive Neurology subsection of the Indian Academy of Neurology in 2023. Internationally, he served as an Atlantic Fellow at UCSF’s GBHI (2020–2021), developing leadership in brain health equity. Dr. Arshad is a member of the American Academy of Neurology and other prestigious forums. He has published widely, initiated clinical trials, and built registries that bridge clinical insights with translational research. His work integrates social science, neurobiology, and global health in addressing dementia across underserved populations.

Awards & Recognitions 🏅

Dr. Faheem Arshad has received numerous recognitions for his contributions to neurology and dementia research. He was awarded the Bursary Award at the TSS International Neuropsychiatry Conference (2018) for his work on social cognition in Frontotemporal Dementia. As the first South Asian to become a Senior Atlantic Fellow for Equity in Brain Health at UCSF’s GBHI, he has been globally recognized for championing equity in dementia care and research. His appointment as Convener of the Cognitive Neurology subsection by the Indian Academy of Neurology in 2023 highlights his leadership within the national academic community. He holds the MRCP(UK) in Neurology and is an active member of prestigious societies, including the American Academy of Neurology. These honors reflect his ongoing commitment to research innovation, community-based care models, and international collaboration in the field of neurodegenerative disorders.

Research Interests 🔬

Dr. Faheem Arshad’s research focuses on dementia, particularly Frontotemporal Dementia (FTD), Alzheimer’s Disease, and related neurodegenerative conditions. He investigates cognitive reserve, biomarkers, social cognition, neuroimaging, and bilingualism in dementia resilience. His landmark projects include exploring the role of social interaction in FTD (GBHI-AA), plasmapheresis in Alzheimer’s (ICMR), cognitive testing in low-literacy settings, and bilingualism’s impact on cognitive reserve (NIH-funded). He co-leads a SERB-funded project using speech features for early dementia detection and a DBT-funded imaging study for vascular dementia diagnosis. He established India’s first cognitive disorders registry at NIMHANS, integrating socio-demographics, imaging, and biomarker data. His work bridges clinical neurology and public health, emphasizing inclusive research for underrepresented populations. A strong advocate for clinical trials in LMICs, his studies integrate AI tools, cross-cultural data, and longitudinal analyses to improve early diagnosis and therapeutic strategies in dementia care.

Publications

Vahid Rashedi | Alzheimer’s disease | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Vahid Rashedi | Alzheimer’s disease | Best Researcher Award

Dr. Vahid Rashedi 👨‍⚕️, an esteemed Assistant Professor of Gerontology at the University of Social Welfare and Rehabilitation Sciences 🇮🇷, has made outstanding global contributions in aging, cognition, and psychogeriatrics 🌍🧠. With a Ph.D. in Gerontology (2017) 🎓 and extensive editorial duties across high-impact journals 📚, he’s actively involved as a Senior Collaborator with the Global Burden of Disease Project at IHME, University of Washington 🇺🇸. Recognized as a Top 1% scientist by Stanford University in 2024 🏅, he combines academic excellence, innovation, and impactful research. His interdisciplinary work spans gerontology, rehabilitation, mental health, and cognitive science, cementing his status as a global leader in aging research 🌐💡.

Profile

Education 🎓

Dr. Rashedi began his academic path with a Bachelor’s and Master’s degree in Rehabilitation Sciences 🎓🦾, focusing on geriatric care and assistive technology. He earned his Ph.D. in Gerontology with distinction in 2017 🥇, building expertise in psychogeriatrics, mental health, and cognitive decline. His academic training was rooted in interdisciplinary frameworks linking medicine, psychology, and social work 🔬💬. This diverse education empowered him to bridge clinical insights with research, enabling innovative health solutions for elderly populations 👵👴. He complements formal education with global scientific memberships and ongoing collaborations with prestigious institutes, such as IHME 🌎, emphasizing lifelong learning and cutting-edge research.

Experience 👨‍🏫

Dr. Rashedi has over a decade of rich academic and research experience, currently serving as Assistant Professor at the University of Social Welfare and Rehabilitation Sciences 🏫. Since 2019, he has been a Senior Collaborator at IHME, University of Washington, contributing to the Global Burden of Disease project 📊🌐. He has authored 126 indexed journal articles 📑, published a book 📖, and holds four patents, including rehabilitation innovations like the vibrating ankle-foot orthosis 🦿. He is a prolific editorial board member and associate editor for over 10 international journals 📘🖋️. His work in psychogeriatrics and cognition has garnered global recognition, highlighting his leadership and mentoring roles 👨‍🏫🏅.

Awards & Recognitions 🏅

Dr. Rashedi is recognized globally for his scientific excellence, notably ranked in the Top 1% of scientists worldwide by Stanford University in 2024 🌟📈. He holds editorial roles in Frontiers, CGJ, and the Journal of Gerontology, reflecting scholarly esteem 📚. He is a trusted reviewer for numerous high-impact journals and was honored with national and international awards 🥇. His patented inventions in geriatric rehabilitation demonstrate a blend of innovation and clinical value 💡🏥. His GSA, APA, and ISTAART memberships validate his international standing 👏🌐. These honors underscore his unwavering dedication to improving elderly lives through evidence-based science and collaboration 🤝

Research Interests 🔬

Dr. Rashedi’s research delves into psychogeriatrics, mental health, and cognitive disorders in aging populations 🧠👴. As part of the Global Burden of Disease team at IHME 🌍, he contributes to global health analytics, shaping international aging policies 📊. His innovations include assistive devices with therapeutic functions, bridging technology and clinical rehabilitation 🛠️⚙️. With 63 research projects and over 26,000 citations 🔍📈, his scholarly output is extensive and impactful. He leads investigations on dementia, geriatric depression, and cognitive resilience, supported by his roles in editorial boards and scientific societies 🧬📘. His mission is to translate research into real-world health solutions for aging communities 🌟🩺.

Publications 

Gerd Fabian Volk | Cognitive Rehabilitation | Outstanding Scientist Award

Published on by Cognitive Scientist Awards

Dr. Gerd Fabian Volk | Cognitive Rehabilitation | Outstanding Scientist Award

apl. Prof. Dr. med. habil. Gerd Fabian Volk (👶1978, Wertheim am Main) is a leading German otolaryngologist 👨‍⚕️, currently serving as Senior Physician and Head of the Facial Nerve Center in Jena 🏥. With a deep commitment to clinical excellence, academic teaching 📚, and innovative research 🧪, he has significantly contributed to the fields of neurolaryngology, facial nerve disorders, and ultrasound diagnostics 🧠🗣️. His work bridges cutting-edge imaging 🖼️ and functional diagnostics for head-neck disorders. Living in Jena with his family 👨‍👩‍👧‍👧, he actively supports patient education through YouTube 📹, coordinates national workshops, and advocates for interdisciplinary collaboration 🤝. Volk is a respected speaker 🎤, faculty member at international dissection courses ✂️🧠, and an initiator of hybrid symposia. He balances leadership with education, translating research into real-world clinical impact 🌍💡.

Profile

Education 🎓

Studied human medicine at Westfälische Wilhelms Universität Münster (1999–2006) 🎓🩺, earning his state exam. In 2007, he completed his doctorate (Dr. med.) with a thesis on axonal regeneration in retinal ganglion cells in primates and rats 🧬🐒🐀. He achieved board certification in ENT (2012) 👂👃🧠 and earned his postdoctoral qualification (habilitation) in 2017 with pioneering research on quantitative imaging of facial muscles 🖼️💪. His venia legendi was granted by Friedrich Schiller University Jena in otorhinolaryngology 📜👨‍🏫. Further qualifications include DEGUM Level II (2018) for ultrasound, clinical trial leadership certification (2009), animal research leadership certification (2002), and interdisciplinary leadership training at UKJ 🏅📊. His broad educational background underpins his medical, scientific, and didactic work, combining clinical care, diagnostics, and teaching for the next generation of ENT specialists 👨‍⚕️👩‍⚕️👨‍🏫.

Experience 👨‍🏫

Since 2013, Dr. Volk leads the Facial Nerve Center in Jena and co-founded the Tinnitus Center 👨‍⚕️🔊. He is currently Senior Physician at the ENT Department, University Hospital Jena and member of the steering committee for the Center for Rare Diseases Jena (since 2024) 🧩🧬. He previously held rotational research fellowships in radiology and neurology (2008–2013) and has organized national ENT courses since 2009 🧠🎓. With consistent academic teaching since 2012, he has led cadaver dissection courses, neurolaryngology workshops, and ultrasound diagnostics trainings 🧑‍🏫💻. He is an active contributor to ethics commissions and rare disease networks 👥⚖️. His work merges clinical ENT practice, surgical skill, and educational outreach through digital platforms (e.g., YouTube, www.lemg.org) 🌐📹. A devoted mentor, he organizes monthly PhD symposia and integrates hybrid teaching formats, balancing high-level medical care with forward-thinking academic initiatives 📚🏥🎯.

Awards & Recognitions 🏅

Recipient of multiple national prizes, including the 1st Poster Prize by the German Society for Ultrasound in Medicine (2019) 🥇📊 for Parkinson-related facial muscle imaging, and the DEGUM Head-Neck Section Award for his habilitation research (2018) 🧠🏅. Awarded competitive IZKF research fellowships in neurology and radiology (2008–2013) 🧬🔬. Recognized leader in rare disease diagnostics and member of Germany’s CRANIO-Net for rare craniofacial disorders (since 2022) 🧩👶. Since 2020, he contributes to the Ethics Commission of the University Hospital Jena ⚖️. He is speaker for ENT indications in the Botulinumtoxin Working Group of the German Society of Neurology (since 2022) 💉🧠. Nominated for professorial posts in Bielefeld, Halle, and Charité Berlin between 2019–2023 🏛️📚. Volk’s sustained excellence across clinical care, diagnostics, research, and education has earned him national recognition and leadership roles in academic ENT medicine 🧠🏥✨.

Research Interests 🔬

Prof. Volk’s research centers on facial nerve diagnostics and therapy 🧠🧑‍⚕️, neurolaryngology, and ultrasound imaging of head-neck structures 🖼️. He specializes in quantitative imaging of facial muscles for conditions like facial paralysis and Parkinson’s disease 🤖🧠. His work combines clinical neurophysiology, MRI analysis, and laryngeal electromyography (LEMG) 📈💬. He also pioneers educational innovations in hybrid learning, simulation-based teaching, and cadaver dissection techniques for ENT and neurology professionals 🧑‍🏫🧪. Through platforms like www.lemg.org and dedicated YouTube channels 📹, he disseminates knowledge on advanced diagnostics such as salivary duct endoscopy, voice disorders, and botulinum toxin use 💉. A strong advocate for interdisciplinary networks and rare disease research, he leads initiatives in patient-centered care, including organizing the “Fazialis-Nerv-Tag” and supporting patient education 🤝❤️. His translational research aims to enhance diagnostic precision and develop novel rehabilitation strategies for complex craniofacial disorders 🧬🔧.

Publications 

  • Electromyography as an Objective Outcome Measure for the Therapeutic Effect of Biofeedback Training to Reduce Post-Paralytic Facial Synkinesis

    Healthcare
    2025-03-04 | Journal article
    DOI: 10.3390/healthcare13050550
    CONTRIBUTORS: Isabell Hahnemann; Julia Fron; Jonas Ballmaier; Orlando Guntinas-Lichius; Gerd Fabian Volk

  • Evaluation of the Effects of an Electromyography-Based Bio-Feedback Training of Patients with Post-Paralytic Facial Synkinesis Using Electromyography Amplitudes as Objective Outcome Measure

    2024-12-16 | Preprint
    DOI: 10.20944/preprints202412.1326.v1
    CONTRIBUTORS: Isabell Hahnemann; Julia Fron; Jonas Ballmaier; Orlando Guntinas-Lichius; Gerd Fabian Volk

  • Deceleration of denervated facial muscle atrophy through functional electrical stimulation: a sonographic quantification in patients with facial nerve paralysis

    European Journal of Translational Myology
    2024-11-13 | Journal article
    DOI: 10.4081/ejtm.2024.13162
    CONTRIBUTORS: Gabriel Meincke; Johannes Krauß; Maren Geitner; Anna-Maria Kuttenreich; Dirk Arnold; Jonas Ballmaier; Thomas Lehmann; Winfried Mayr; Orlando Guntinas-Lichius; Gerd Fabian Volk

Jeevitha Gowda R | Cognitive impairment | Best Researcher Award

Published on by Cognitive Scientist Awards

Ms. Jeevitha Gowda R | Cognitive impairment | Best Researcher Award

Assistant Professor, Alliance University, United Kingdom

🧠 Dr. Jeevitha Gowda R is a dedicated research scholar specializing in cognitive neuroscience and public health, with a strong focus on dementia prevention. She has expertise in developing cognitive screening tools, conducting neuropsychological assessments, and designing neuroscience-based interventions to enhance brain health. Currently serving as a Guest Faculty and Research Associate, she is passionate about bridging research with real-world applications. With proficiency in EEG, ERP, and data analysis, her work emphasizes cognitive aging, behavioral psychology, and mental well-being. Her research contributions include multiple conference presentations, publications, and cognitive training programs. She has received prestigious recognitions, including Best Paper Awards and research fellowships. Her commitment extends to community mental health programs, where she collaborates with NGOs and research institutions. Through her work, she aims to advance cognitive neuroscience and improve public health outcomes. 📚🔬

Profile

Education 🎓

🎓 Dr. Jeevitha Gowda R holds a Ph.D. in Cognitive Neuroscience and Public Health from Ramaiah University of Applied Sciences, Bengaluru (Thesis Submitted), focusing on developing cognitive tools for early dementia detection in primary healthcare settings. She earned a Master’s in Cognitive Neuroscience from JSS Academy of Higher Education, Mysuru (2018), ranking among the top 3 students, with coursework in neural cognition, psychological assessment, and clinical interventions. Her dissertation explored mental fatigue due to sleep deprivation using EEG and ERP. She completed her Bachelor’s in Life Sciences from JSS College for Women, Mysuru (2016), excelling in biochemistry, microbiology, and environmental psychology. Additionally, she trained at the Defence Institute of Psychological Studies (DRDO) and Narayana Health, Bengaluru, gaining hands-on experience in EEG, neuropsychological assessments, and cognitive therapy. Her interdisciplinary education combines neuroscience, psychology, and public health, preparing her for impactful research and innovation in brain health. 🧠📖

Experience 👨‍🏫

💼 Dr. Jeevitha Gowda R has extensive experience as a Research Associate at the Centre for Integrative Health and Well-Being (2020–Present), where she develops neuropsychological intervention tools and conducts cognitive behavioral therapy (CBT) programs. She also serves as a Senior Research Associate at Brighter Minds, focusing on cognitive enhancement and neuroscience-based training programs. As a Guest Lecturer at Ramaiah University of Applied Sciences (2021–Present), she teaches biostatistics, neurophysiology, and psychology. Her past clinical internships at DRDO and Narayana Health provided her with hands-on expertise in EEG, ERP, and neuropsychological assessments. She has conducted research on cognitive impairment, dementia screening, and sleep deprivation’s effects on cognition. Additionally, she has authored 50+ neuroscience articles, presented at international conferences, and collaborated with NGOs for mental health awareness. Her diverse experience integrates academic, clinical, and research-based expertise to advance cognitive neuroscience and public health. 🏥📊

Research Interests 🔬

🔬 Dr. Jeevitha Gowda R’s research bridges cognitive neuroscience, psychology, and public health, focusing on early dementia detection, cognitive aging, and neuropsychological interventions. She specializes in developing culturally relevant cognitive screening tools for primary healthcare, improving accessibility to dementia diagnostics. Her work explores neuropsychological assessments, EEG-based cognitive analysis, and behavioral interventions for enhancing mental well-being. She has conducted studies on sleep deprivation, cognitive impairment, and neurofeedback therapy. She collaborates with institutions like DRDO, Narayana Health, and Brighter Minds to implement neuroscience-driven programs. Her research extends to the psychological well-being of dementia caregivers, neurocognitive training for brain health, and integrating technology into mental health solutions. Through interdisciplinary studies and global research collaborations, she aims to advance early dementia detection methods and improve cognitive health strategies. Her work contributes to policy-making, clinical psychology, and public health initiatives. 🏥📊

Awards & Recognitions 🏅

🏆 Dr. Jeevitha Gowda R has received multiple accolades for her contributions to cognitive neuroscience and public health research. She won the Best Paper Award at the Epidemiology Foundation of India Conference (2023, Goa) for her groundbreaking work on dementia screening. Her research paper on cognitive tool validation earned a Special Mention at the International Dementia Conference (DEMCON-2024, IISC Bangalore). During her master’s, she ranked among the top 3 dissertations at JSS Academy of Higher Education. She was awarded the Senior Research Fellowship (SRF) by Ramaiah University of Applied Sciences (2022–2024) for her Ph.D. research. She has also secured research grants for projects on dementia detection and cognitive enhancement. Recognized for her impactful contributions, she collaborates with prestigious institutions, including DRDO and Narayana Health, to advance neuropsychological research. Her work continues to shape innovations in mental health and aging. 🎖️🧠

Publications 📚

  • Jeevitha Gowda R, Anish Mehta, Krishnamurthy Jayanna. (2025).
    Dementia: A Public Health Challenge in India. South Eastern European
    Journal of Public Health, 29–43. Retrieved from
    hps://www.seejph.com/index.php/seejph/article/view/3295 (Scopus)

  • Jeevitha Gowda R. The Impact of Cultural Beliefs and Stigma on
    Dementia Care and Diagnosis: A Scoping Review, 25 November 2024,
    PREPRINT (Version 1) available at Research Square
    hps://doi.org/10.21203/rs.3.rs-5519592/v1
  • Jeevitha Ramesh, Parimala Guruprasad (2024) Factors Affecting the
    Psychological Well-Being of Caregivers of Dementia Patients: A
    Thematic Review. Journal of Neurology Research Reviews & Reports.
    SRC/JNRRR-260
  • Development and Validation of Cognitive Screening Tools for
    Dementia Detection in Primary Care Seings: An Exploratory Pilot
    Study – Under review at International Journal of Geriatric Psychiatry.
    (Corresponding Author)
  • Burden of Cognitive Impairment Including Dementia, and Associated
    Risk Factors Among the Rural Population of South Karnataka, India –
    Under review at Journal of Public Health Research. (Corresponding
    Author)
  • Impact of Training Module on Lifestyle and Healthy Behaviours: An
    Exploratory Pilot in India – Under review at Journal Explore.
    (Co-Author)

Gerardo Fernandez | Eye tracking | Excellence in Innovation

Published on by Cognitive Scientist Awards

Dr. Gerardo Fernandez | Eye tracking | Excellence in Innovation

Gerardo Abel Fernández 🇦🇷, born on October 29, 1976, in Bahía Blanca, Argentina, is a researcher specializing in neuroscience and cognitive science 🧠. He is a professor and adjunct researcher at CONICET, focusing on eye movement-based biomarkers for neurodegenerative diseases 👀. His work integrates philosophy, cognitive psychology, and technology to advance Alzheimer’s diagnosis 🏥.

Profile

Education 🎓

🎓 Gerardo Abel Fernández obtained a degree in Philosophy (2003) from Universidad Nacional del Sur (UNS), Argentina, with a specialization in Logic and Epistemology. He later pursued a PhD in Philosophy (2011) at UNS, with his thesis titled “Dynamic word processing during reading: Mental strategies driving visual exploration”, earning a perfect 10/10 with special mention. His academic journey includes postdoctoral research as a fellow at AGENCIA (ANPCYT) and the DAAD Max Planck Institute in Berlin. His educational background bridges philosophy, neuroscience, and cognitive psychology, forming a solid foundation for his pioneering research in eye movement analysis and Alzheimer’s biomarkers. His expertise in cognitive science and technological innovation has led to the development of diagnostic tools for early neurodegenerative disease detection. 📚🔍🧠

Experience 👨‍🏫

💼 Dr. Gerardo Abel Fernández has extensive experience in neuroscience research and technological innovation. He served as a Professor of Audiovisual Language at UNS (2011–2013) and is currently an Adjunct Researcher at CONICET, focusing on non-endemic degenerative pathologies. He has worked as a Visiting Scholar at Heriot-Watt University and Strathclyde University (UK), contributing to the development of eye-tracking biomarkers for Alzheimer’s disease. Dr. Fernández is also a scientific reviewer for prestigious journals like PlosOne, Journal of Alzheimer’s Disease, and Neuropsychologia. As CTO of Viewmind, he leads biocognitive and functional performance measurement innovations. He has patented cognitive evaluation methods and received grants from institutions like ANPCYT and DAAD. His interdisciplinary expertise spans cognitive neuroscience, machine learning applications in diagnostics, and technological development for neurodegenerative disease assessment. 🏅🔬👁️

Research Interests 🔬

🔬 Dr. Gerardo Abel Fernández specializes in cognitive neuroscience, neurodegenerative disease biomarkers, and eye-tracking technology. His research focuses on early Alzheimer’s detection through oculomotor behavior analysis. He has developed innovative methods to study visual exploration, reading difficulties, and memory impairments in neurodegenerative conditions. His work integrates machine learning and artificial intelligence for cognitive assessment tools. As a Visiting Scholar in the UK, he contributed to developing biomarkers for Alzheimer’s disease. His patented eye-tracking system has clinical applications in detecting mild cognitive impairment and Alzheimer’s disease. He has published extensively in peer-reviewed journals, exploring predictive eye movement models and their correlation with cognitive decline. His cutting-edge research bridges philosophy, neuroscience, and technology, offering non-invasive diagnostic solutions for early-stage neurodegeneration. His ultimate goal is to revolutionize cognitive healthcare through technological innovation. 🧠👁️📊

Awards & Recognitions 🏅

🏆 Dr. Gerardo Abel Fernández has received numerous awards for his contributions to neuroscience, cognitive evaluation, and Alzheimer’s diagnostics. His eye-tracking research for Alzheimer’s detection earned the Dr. José Borda Clinical Psychiatry Prize at the 22nd International Congress of Psychiatry. He won the Novartis Innovation Award for his work on measuring cognitive performance in health and disease. As CTO of Viewmind, his team received international recognition, including the Fit4Start Luxembourg Award for health applications and the Medica Innovation Prize in Düsseldorf. His research and patented cognitive evaluation equipment have been acknowledged by ANMAT (Argentina’s National Administration of Drugs, Foods, and Medical Technology) and INPI (Argentina’s National Patent Office). Dr. Fernández’s groundbreaking innovations in neurocognitive assessments have positioned him as a leading figure in technological advancements for early Alzheimer’s detection. 🏅🧠🔬

Publications 📚

  • Oculomotor behaviors and integrative memory functions in the alzheimer’s clinical syndrome

    Journal of Alzheimer’s Disease
    2021 | Journal article
    DOI: 10.3233/JAD-201189

  • A non-invasive tool for attention-deficit disorder analysis based on gaze tracks.

    ACM International Conference Proceeding Series
    2019 | Conference paper
    DOI: 10.1145/3309772.3309777

  • Microsaccadic behavior when developing a complex dynamical activity

    Journal of Integrative Neuroscience
    2018 | Journal article
    DOI: 10.3233/JIN-170057

    EID:

    2-s2.0-85053731401

Marcelo Luis Berthier | Neuroscience| Best Researcher Award

Published on by Cognitive Scientist Awards

Prof. Marcelo Luis Berthier | Neuroscience| Best Researcher Award

 

Unversidad de Málaga, Spain

Profile

Education

Marcelo Luis Berthier obtained his degree in Medicine (1972-1976) and completed residency training in Neurosurgery (1977-1980), later specializing in Neurology (1980). He served as a staff neurologist at the Institute of Neurological Research, FLENI, Buenos Aires, Argentina (1980-1989), before becoming a research fellow in the Department of Neurology at Clinic Hospital of Barcelona, Spain (1989-1990). From 1991 to 2000, he was a staff neurologist and physician in charge of the Behavioural Neurology Unit at the Clinic University Hospital of Malaga. He earned a PhD in Neuroscience (cum laude) from the University of Malaga and coordinated the Group of Behavioural Neurology and Dementia of the Spanish Neurological Society (2004-2006). In 2004, he founded and directed the Unit of Cognitive Neurology and Aphasia at the Centro de Investigaciones Médico-Sanitarias, University of Malaga, leading it until 2023. Additionally, he served as the director of the Consolidated Research Group on Cognitive Neuroscience: Aphasia and Related Disorders (UNCA, C-12) at the Instituto de Investigación Biomédica de Málaga (IBIMA – Plataforma BIONAND).

Work experience

Dr. Marcelo L. Berthier Torres has led and contributed to several groundbreaking research projects in cognitive neurology and aphasia. As a co-investigator, he participated in the Telerehabilitation in Aphasia project (2021-2023), which evaluated the effectiveness of telerehabilitation compared to face-to-face therapy and identified predictive biomarkers of response, funded by the Junta de Andalucía. He also served as the principal investigator for a study on the efficacy of combined treatment with donepezil, intensive rehabilitation, and transcranial direct current stimulation in chronic post-stroke aphasia (2016-2019), funded by the Instituto de Salud Carlos III. Additionally, he has contributed to the Proyectos de Generación de Conocimiento “Frontera”, an initiative under the FEDER Andalucía 2014-2020 program, which investigates brain biomarkers for individualized treatment approaches in chronic post-stroke aphasia

Areas of Research

Dr. Marcelo L. Berthier Torres has made significant contributions to the treatment of post-stroke aphasia and speech-language disorders. He conducted the first open-label and randomized, placebo-controlled, double-blind trials investigating the use of cognitive-enhancing drugs (donepezil and memantine) alone and in combination with standard aphasia therapy or intensive language-action therapy (ILAT) in chronic post-stroke aphasia. His pioneering studies stimulated international research on aphasia pharmacotherapy, leading to clinical translation. Today, donepezil and memantine, alone or combined with therapy, are widely used off-label for post-stroke aphasia and language disturbances associated with neurodegenerative disorders like Alzheimer’s disease and primary progressive aphasia.

Publication

  • Revisiting the boundaries of different altered accents profiles

    Cortex
    2025-03 | Journal article
    DOI: 10.1016/j.cortex.2025.01.001
    CONTRIBUTORS: Marcelo L. Berthier; Ignacio Moreno-Torres; Jo Verhoeven; Guadalupe Dávila

  • Turning the Spotlight to Cholinergic Pharmacotherapy of the Human Language System

    CNS Drugs
    2023-07 | Journal article
    DOI: 10.1007/s40263-023-01017-4
    CONTRIBUTORS: Guadalupe Dávila; María José Torres-Prioris; Diana López-Barroso; Marcelo L. Berthier

  • Pharmacotherapy for post-stroke aphasia: what are the options?

    Expert Opinion on Pharmacotherapy
    2023-07-24 | Journal article
    DOI: 10.1080/14656566.2023.2221382
    CONTRIBUTORS: Marcelo L. Berthier; Guadalupe Dávila

  • Brain structural and functional correlates of the heterogenous progression of mixed transcortical aphasia

    Brain Structure and Function
    2023-05-31 | Journal article
    DOI: 10.1007/s00429-023-02655-6
    CONTRIBUTORS: Diana López-Barroso; José Paredes-Pacheco; María José Torres-Prioris; Guadalupe Dávila; Marcelo L. Berthier

  • Controlling the past, owning the present, and future: cholinergic modulation decreases semantic perseverations in a person with post-stroke aphasia

    Aphasiology
    2022-11-02 | Journal article
    DOI: 10.1080/02687038.2021.1957082
    CONTRIBUTORS: Marcelo L. Berthier; Daniel Santana-Moreno; Álvaro Beltrán-Corbellini; Juan C. Criado-Álamo; Lisa Edelkraut; Diana López-Barroso; Guadalupe Dávila; María José Torres-Prioris